gdc-0853
Showing 1 - 11 of 11
Lymphocytic Leukemia, Chronic, DLBCL Trial in Australia, United States (GDC-0853)
Completed
- Lymphocytic Leukemia, Chronic, Diffuse Large B-Cell Lymphoma
- GDC-0853
-
Stanford, California
- +9 more
Jun 16, 2022
Healthy Volunteer Trial in Nottingham (Folic Acid, GDC-0853, Methotrexate)
Completed
- Healthy Volunteer
- Folic Acid
- +3 more
-
Nottingham, United KingdomQuotient Clinical Ltd, Clinical Research Unit
Feb 27, 2020
Lupus Erythematosus, Systemic Trial in Worldwide (GDC-0853)
Terminated
- Lupus Erythematosus, Systemic
- GDC-0853
-
Los Alamitos, California
- +52 more
Nov 24, 2020
Healthy Volunteers Trial in Nottingham (GDC-0853, Rabeprazole)
Completed
- Healthy Volunteers
- GDC-0853
- Rabeprazole
-
Nottingham, United KingdomQuotient Clinical Ltd, Clinical Research Unit
Sep 10, 2019
Healthy Volunteer Trial in Cypress (GDC-0853, Placebo)
Completed
- Healthy Volunteer
- GDC-0853
- Placebo
-
Cypress, CaliforniaWest Coast Clinical Trials
Aug 5, 2019
Systemic Lupus Erythematosus Trial in Worldwide (GDC-0853, Placebo)
Completed
- Systemic Lupus Erythematosus
- GDC-0853
- Placebo
-
Birmingham, Alabama
- +69 more
Jun 22, 2020